These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 19082705

  • 21. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer.
    Hooning MJ, Aleman BM, Hauptmann M, Baaijens MH, Klijn JG, Noyon R, Stovall M, van Leeuwen FE.
    J Clin Oncol; 2008 Dec 01; 26(34):5561-8. PubMed ID: 18854572
    [Abstract] [Full Text] [Related]

  • 22. [Bilateral primary breast cancer: a report of 217 cases].
    Zhang T, Zhang BN.
    Zhonghua Zhong Liu Za Zhi; 2004 Dec 01; 26(12):756-8. PubMed ID: 15733399
    [Abstract] [Full Text] [Related]

  • 23. Adherence to quality indicators and survival in patients with breast cancer.
    Cheng SH, Wang CJ, Lin JL, Horng CF, Lu MC, Asch SM, Hilborne LH, Liu MC, Chen CM, Huang AT.
    Med Care; 2009 Feb 01; 47(2):217-25. PubMed ID: 19169123
    [Abstract] [Full Text] [Related]

  • 24. Incidence and prognosis of synchronous and metachronous bilateral breast cancer.
    Hartman M, Czene K, Reilly M, Adolfsson J, Bergh J, Adami HO, Dickman PW, Hall P.
    J Clin Oncol; 2007 Sep 20; 25(27):4210-6. PubMed ID: 17878475
    [Abstract] [Full Text] [Related]

  • 25. [Bilateral breast cancer. Incidence and risk factors].
    El Hanchi Z, Berrada R, Fadli A, Ferhati D, Brahmi R, Baydada A, Kharbach A, Chaoui A.
    Gynecol Obstet Fertil; 2004 Feb 20; 32(2):128-34. PubMed ID: 15123135
    [Abstract] [Full Text] [Related]

  • 26. Breast cancer multifocality, disease extent, and survival.
    Tot T, Gere M, Pekár G, Tarján M, Hofmeyer S, Hellberg D, Lindquist D, Chen TH, Yen AM, Chiu SY, Tabár L.
    Hum Pathol; 2011 Nov 20; 42(11):1761-9. PubMed ID: 21663941
    [Abstract] [Full Text] [Related]

  • 27. Breast conserving surgery for multifocal breast cancer.
    Lim W, Park EH, Choi SL, Seo JY, Kim HJ, Chang MA, Ku BK, Son B, Ahn SH.
    Ann Surg; 2009 Jan 20; 249(1):87-90. PubMed ID: 19106681
    [Abstract] [Full Text] [Related]

  • 28. Prognosis of women with pT4b breast cancer: the significance of this category in the TNM system.
    Harms K, Wittekind C.
    Eur J Surg Oncol; 2009 Jan 20; 35(1):38-42. PubMed ID: 18215492
    [Abstract] [Full Text] [Related]

  • 29. Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis.
    Tuthill M, Pell R, Guiliani R, Lim A, Gudi M, Contractor KB, Lewis JS, Coombes RC, Stebbing J.
    Eur J Cancer; 2009 Aug 20; 45(12):2146-9. PubMed ID: 19464163
    [Abstract] [Full Text] [Related]

  • 30. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
    Karam AK, Stempel M, Barakat RR, Morrow M, Gemignani ML.
    Gynecol Oncol; 2009 Mar 20; 112(3):490-5. PubMed ID: 19101713
    [Abstract] [Full Text] [Related]

  • 31. Men with breast cancer have same disease-specific and event-free survival as women.
    Marchal F, Salou M, Marchal C, Lesur A, Desandes E.
    Ann Surg Oncol; 2009 Apr 20; 16(4):972-8. PubMed ID: 19184227
    [Abstract] [Full Text] [Related]

  • 32. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
    Lawrence G, Wallis M, Allgood P, Nagtegaal ID, Warwick J, Cafferty FH, Houssami N, Kearins O, Tappenden N, O'Sullivan E, Duffy SW.
    Breast Cancer Res Treat; 2009 Jul 20; 116(1):179-85. PubMed ID: 18622697
    [Abstract] [Full Text] [Related]

  • 33. Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival.
    Mery CM, George S, Bertagnolli MM, Raut CP.
    Cancer; 2009 Sep 15; 115(18):4055-63. PubMed ID: 19526590
    [Abstract] [Full Text] [Related]

  • 34. Prognostic relevance of cyclin E expression in operable breast cancer.
    Potemski P, Kusińska R, Pasz-Walczak G, Piekarski JH, Watała C, Płuciennik E, Bednarek AK, Kordek R.
    Med Sci Monit; 2009 Feb 15; 15(2):MT34-40. PubMed ID: 19179977
    [Abstract] [Full Text] [Related]

  • 35. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
    Millar EK, Graham PH, O'Toole SA, McNeil CM, Browne L, Morey AL, Eggleton S, Beretov J, Theocharous C, Capp A, Nasser E, Kearsley JH, Delaney G, Papadatos G, Fox C, Sutherland RL.
    J Clin Oncol; 2009 Oct 01; 27(28):4701-8. PubMed ID: 19720911
    [Abstract] [Full Text] [Related]

  • 36. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A, Guray M, Hennessy BT, Middleton LP, Buchholz TA, Valero V, Sahin AA.
    Cancer; 2009 Apr 15; 115(8):1605-12. PubMed ID: 19197997
    [Abstract] [Full Text] [Related]

  • 37. Influence of radiotherapy for the first tumor on aggressiveness of contralateral breast cancer.
    Sandberg ME, Alkner S, Hartman M, Eloranta S, Rydén L, Ploner A, Adami HO, Hall P, Czene K.
    Int J Cancer; 2013 May 15; 132(10):2388-94. PubMed ID: 23034813
    [Abstract] [Full Text] [Related]

  • 38. Primary tumor resection improves the survival of younger patients with metastatic breast cancer.
    Shien T, Kinoshita T, Shimizu C, Hojo T, Taira N, Doihara H, Akashi-Tanaka S.
    Oncol Rep; 2009 Mar 15; 21(3):827-32. PubMed ID: 19212646
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer.
    Nout RA, Fiets WE, Struikmans H, Rosendaal FR, Putter H, Nortier JW.
    Breast Cancer Res Treat; 2008 Jun 15; 109(3):567-72. PubMed ID: 17661169
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.